文献速递腹部CT

胰腺内晚期强化:胰腺腺癌早期阶段值得注意的影像表现

A retrospective preliminary study of intrapancreatic late enhancement as a noteworthy imaging finding in the early stages of pancreatic adenocarcinoma.
PubMed 文献 · Eur Radiol · 2023-01-17

本研究回顾性纳入32例有诊断前6个月至5年胰腺增强CT的胰腺腺癌患者,评估包括胰腺内晚期强化(ILE)在内的间接征象。23例出现间接征象,14例(63%)见ILE,中位诊断间隔17个月。认识ILE可使观察者多检出2-3个胰头病灶,观察者间一致性从差(k=0.17)升至中等(k=0.55)。

要点

  • ILE是胰腺腺癌早期检测的重要间接征象,可单独出现。
  • 单独ILE更常见于胰头病灶,有助于检出胰头病变。
  • 关注ILE可提高病灶检出数并改善观察者间一致性。

核心结论

  • ILE是胰腺腺癌早期检测的重要间接征象。
  • 不伴其他间接征象的ILE有助于检出胰头病灶。
  • 关注ILE的影像评估可增加病灶检出并改善观察者间一致性。

研究设计与样本

  • 回顾性研究,纳入203例病理诊断胰腺腺癌患者中32例有诊断前6个月至5年腹部增强CT者。
  • 评估诊断前CT上的间接征象(包括ILE),并分析临床数据及至诊断时间间隔。
  • 对检出的ILE进行定量评估,并评估两名放射科医生对ILE的认知对病灶检出的影响及观察者间一致性。

关键影像表现/征象

  • 32例中23例显示间接征象,14例(63%)观察到ILE,中位至诊断时间间隔17个月(IQR:9.3-42.3)。
  • ILE单独出现8例(35%),ILE伴局灶性胰腺实质萎缩5例(22%),ILE伴主胰管异常1例(4%)。
  • 单独ILE组胰头病变更常见于局灶性胰腺实质萎缩或主胰管异常组(p=0.026)。
  • ILE区域长轴直径中位数10 mm(IQR:5-11),ILE与胰腺对比中位数24 HU(IQR:17-33)。

诊断标准与关键数值

  • ILE定义为胰腺内晚期强化,定量评估长轴直径中位数10 mm(IQR:5-11),对比中位数24 HU(IQR:17-33)。
  • 认识ILE后观察者多检出2或3个胰头病灶,观察者间一致性从差(k=0.17)升至中等(k=0.55)。

临床应用与阅片要点

  • 阅片时应关注胰腺内晚期强化,尤其是不伴其他间接征象时,可能提示早期胰腺腺癌。
  • 单独ILE更常见于胰头病灶,对胰头区域应仔细评估。
  • 关注ILE可提高病灶检出数并改善观察者间一致性。

局限性

  • 回顾性研究,样本量较小(32例),仅纳入有诊断前CT的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To characterize intrapancreatic late enhancement (ILE) observed in the early stages of pancreatic adenocarcinoma (PAC).

METHODS: Among 203 patients pathologically diagnosed with PAC between October 2011 and February 2021, 32 patients with pre-diagnostic abdominal contrast-enhanced CT performed from 6 months to 5 years before the diagnosis were enrolled in this study. Indirect findings (IFs) on pre-diagnostic CT, including ILE, were evaluated and examined for various clinical data and time intervals to diagnosis (TIDs). The detected ILE was quantitatively evaluated, and the effect of ILE awareness on lesion detection by two radiologists and their interobserver agreement were assessed.

RESULTS: Among the 32 patients, 23 showed IFs. ILE was observed in 14 patients (63%), with a median TID of 17 months (interquartile ratio [IQR]: 9.3-42.3). ILE alone was observed in eight patients (35%), ILE with focal pancreatic parenchymal atrophy (FPPA) was observed in five patients (22%), and ILE with main pancreatic duct abnormalities (MPDA) was observed in one patient (4%). Pancreatic head lesions were significantly more frequent in patients with ILE alone than in patients with FPPA or MPDA (p = 0.026). The median long-axis diameters of the region with ILE and ILE-to-pancreas contrast were 10 (IQR: 5-11) mm and 24 (IQR: 17-33) HU, respectively. Awareness of ILE led observers to detect two or three more pancreatic head lesions, and interobserver agreement increased from poor agreement (k = 0.17) to moderate agreement (k = 0.55).

CONCLUSION: ILE is a significant IF for early PAC detection.

KEY POINTS: • Intrapancreatic late enhancement (ILE) is a significant indirect finding in the early detection of pancreatic adenocarcinoma. • ILE without other indirect findings is expected to help detect pancreatic head lesions. • Image evaluation focusing on ILE can increase lesion detection and improve the interobserver agreement.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Konno, Sugai, Kanoto, et al. A retrospective preliminary study of intrapancreatic late enhancement as a noteworthy imaging finding in the early stages of pancreatic adenocarcinoma. Eur Radiol. 2023. PMID: 36648551. doi:10.1007/s00330-022-09388-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。